UBS Group’s Xtrackers Risk Managed USD High Yield Strategy ETF HYRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-201
Closed -$4.63K 10704
2026
Q1
$4.63K Buy
201
+138
+219% +$3.22K ﹤0.01% 8908
2025
Q4
$1.47K Sell
63
-3,368
-98% -$78.9K ﹤0.01% 9572
2025
Q3
$81.1K Sell
3,431
-1,071
-24% -$25.1K ﹤0.01% 7253
2025
Q2
$106K Buy
4,502
+3,168
+237% +$73.2K ﹤0.01% 7193
2025
Q1
$31.4K Buy
1,334
+961
+258% +$22.7K ﹤0.01% 7915
2024
Q4
$8.75K Buy
373
+213
+133% +$5.06K ﹤0.01% 8389
2024
Q3
$3.85K Sell
160
-256
-62% -$6.02K ﹤0.01% 8216
2024
Q2
$9.6K Buy
416
+341
+455% +$7.84K ﹤0.01% 7738
2024
Q1
$1.74K Buy
+75
New +$1.73K ﹤0.01% 8065
2023
Q3
Sell
-909
Closed -$20.4K 9675
2023
Q2
$20.4K Sell
909
-287
-24% -$6.4K ﹤0.01% 6859
2023
Q1
$27K Buy
1,196
+1,195
+119,500% +$26.7K ﹤0.01% 6865
2022
Q4
$22 Sell
1
-1,666
-100% -$36.7K ﹤0.01% 10548
2022
Q3
$36K Buy
+1,667
New +$37.7K ﹤0.01% 6661

UBS Group's HYRM Position: Q2 2026 in Review

UBS Group sold out of Xtrackers Risk Managed USD High Yield Strategy ETF (HYRM) in Q2 2026, closing a stake of 201 shares — an estimated $4.63K sold.

UBS Group first reported a position in HYRM in Q3 2022 and held it in 13 quarters. The position peaked at $106K in Q2 2025. 0 funds tracked by Wall St. Rank hold HYRM as of Q2 2026.

  • UBS Group reported no remaining Xtrackers Risk Managed USD High Yield Strategy ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 201 Xtrackers Risk Managed USD High Yield Strategy ETF shares in Q2 2026, an estimated $4.63K.
  • UBS Group first reported a position in Xtrackers Risk Managed USD High Yield Strategy ETF in Q3 2022 and held it in 13 quarters.
  • UBS Group's Xtrackers Risk Managed USD High Yield Strategy ETF position peaked at $106K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Xtrackers Risk Managed USD High Yield Strategy ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.